Skip to Main Content

Paper Details

Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound.
Clin Cancer Res
17
2023
ATM, BRCA, BRCA1, BRCA2, Circulating Tumor, Circulating Tumor DNA, PARP, Patients, Prostate Cancer, Tumor, Tumor tissue, cancers, ctDNA, ctDNA samples, homologous recombination repair genes, mCRPC, metastatic castration-resistant prostate cancer, patients, plasma, tumor
Author NameAffiliation
Kim N Chi
Zhongwu Lai
J. Carl Barrett
Neeraj AgarwalHuntsman Cancer Institute, University of Utah (NCI-CCC)
Arun A AzadPeter MacCallum Cancer Centre
Johann S de BonoThe Institute of Cancer Research and The Royal Marsden
Joaquin MateoVall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital
  • 1 - 7

Datasets

Release 1.2